- Home
- CTSO vs NSRX Comparison
CTSO vs NSRX Comparison
Compare CTSO & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- NSRX
- Stock Information
- Founded
- CTSO 1997
- NSRX N/A
- Country
- CTSO United States
- NSRX Israel
- Employees
- CTSO N/A
- NSRX N/A
- Industry
- CTSO Medical/Dental Instruments
- NSRX Biotechnology: Pharmaceutical Preparations
- Sector
- CTSO Health Care
- NSRX Health Care
- Exchange
- CTSO Nasdaq
- NSRX Nasdaq
- Market Cap
- CTSO 61.7M
- NSRX 73.0M
- IPO Year
- CTSO N/A
- NSRX 2025
- Fundamental
- Price
- CTSO $1.00
- NSRX $8.00
- Analyst Decision
- CTSO Buy
- NSRX
- Analyst Count
- CTSO 2
- NSRX 0
- Target Price
- CTSO $5.50
- NSRX N/A
- AVG Volume (30 Days)
- CTSO 123.9K
- NSRX 47.1K
- Earning Date
- CTSO 11-06-2025
- NSRX 01-01-0001
- Dividend Yield
- CTSO N/A
- NSRX N/A
- EPS Growth
- CTSO N/A
- NSRX N/A
- EPS
- CTSO N/A
- NSRX N/A
- Revenue
- CTSO $36,107,520.00
- NSRX N/A
- Revenue This Year
- CTSO $11.93
- NSRX N/A
- Revenue Next Year
- CTSO $21.22
- NSRX N/A
- P/E Ratio
- CTSO N/A
- NSRX N/A
- Revenue Growth
- CTSO 20.18
- NSRX N/A
- 52 Week Low
- CTSO $0.71
- NSRX $7.23
- 52 Week High
- CTSO $1.61
- NSRX $9.99
- Technical
- Relative Strength Index (RSI)
- CTSO 52.14
- NSRX N/A
- Support Level
- CTSO $0.94
- NSRX N/A
- Resistance Level
- CTSO $0.99
- NSRX N/A
- Average True Range (ATR)
- CTSO 0.07
- NSRX 0.00
- MACD
- CTSO 0.01
- NSRX 0.00
- Stochastic Oscillator
- CTSO 82.21
- NSRX 0.00
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.